Recruiting NCT06500312
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Lung Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Assessment the Association of Imaging and Tumor Microenvironment in Lung Cancer With Radiogenomics
Overview
This is the prospective, observational cohort study (Radiogenomics-Lung), which aims to explore the relationship between the imaging information of lung cancer patients, tumor microenvironment and the prognosis of lung cancer patients.
Primary outcome measures
- Correlation analysis of sequencing results and body composition [Time frame: 0.5 year]
- Correlation analysis of sequencing results and tumor radiomic features [Time frame: 0.5 year]
Secondary outcome measures (2)
- Constructing tumor microenvironment prediction model [Time frame: 2 years]
- Constructing a multi-dimensional prognostic prediction model [Time frame: 3 years]
Eligibility criteria
Inclusion criteria
- Patients were treated for lung cancer in Wuhan Union Hospital from July 2024 to July 2027;
- Aged > 18 years old;
- At least one chest CT scan before treatment;
- Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion criteria
- Poor image quality;
- Incomplete clinical data or loss of follow-up;
- Presence of another primary malignancy other than lung cancer;
- Unclear pathological diagnosis。
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan
Identifiers
NCT: NCT06500312 · 0482